HK1: A Novel Antibiotic Candidate
The fight against antibiotic resistance is a global health imperative, driving the urgent need for novel therapeutic solutions. In this arena, HK1 has emerged as a compelling candidate. This molecule exhibits remarkable activity against a broad spectrum of bacterial pathogens, including MDR strains